Healthcare

PRODUCTS

  • With a portfolio of over 5,000 recombinant proteins and an industry-leading, scale-up ready protein development platform, ACROBiosystems has accumulated over 10 years of experience in developing recombinant proteins.

  • Understanding the fine details of powder properties is crucial in the pharmaceutical industry, where the behavior of particulate matter can affect manufacturability and the efficacy of the final product.

  • Natoli Scientific’s preclinical stability studies represent a critical facet of our pharmaceutical testing services, providing essential data on the shelf life and storage conditions of drug candidates. These studies are expertly designed to evaluate physical, chemical, and microbiological stability, ensuring that formulations retain their safety, efficacy, and quality over time. Our state-of-the-art facilities simulate various environmental conditions to scrutinize the integrity of products under stress-testing scenarios. The results gleaned from our stability studies guide the development of robust drug formulations and packaging, aid in regulatory submissions, and lay the groundwork for successful commercialization.

  • Technology solutions for life sciences that get products to market quickly and efficiently.

  • Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.

WHITE PAPERS AND CASE STUDIES

NEWS

  • Samtec To Exhibit At OFC 2026, Participate In OIF Interoperability Demo
    3/10/2026

    Samtec, Inc., the service leader in the connector industry, will be demonstrating next-generation, high-performance optical and copper interconnect solutions in South Hall booth #1101 at the upcoming OFC exhibition (March 17-19 at Los Angeles Convention Center, Los Angeles, CA).

  • Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift
    8/11/2025

    Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.

  • Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
    10/20/2025

    AI-powered platform built on Google Cloud automates clinical trial tasks, reducing time, cost, and errors while generating regulatory-grade real-world evidence through human-supervised automation.

  • AmpliTech Group Announces Innovative True 5G Technology Development
    2/20/2025

    AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced, it is setting the record straight on what constitutes True 5G and how its revolutionary technology is paving the way for the future of wireless connectivity.

  • Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, And New Jersey Healthcare Networks
    3/28/2025

    Daxor Corporation (Nasdaq: DXR), Daxor, the global leader in blood volume measurement technology, today announces a significant expansion into three regional healthcare facilities across the U.S. These facilities will use Daxor's Tennessee-based ezBVA Lab, a CLIA-certified facility equipped with state-of-the-art technology.